SuperworthEdesa Biotech shares outstanding EDSA
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Dec 31, 2021
- 1.9M
- On a year earlier
- +29.9%
- more shares
Edesa Biotech had 1.9M diluted shares outstanding on average in Q1 FY22, the quarter to Dec 31, 2021.
That is 29.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2021 | 1.9M | +42% |
| FY2020 | 1.3M | +24% |
| FY2019 | 1.1M | +740% |
| FY2018 | 127.7K | +257% |
| FY2017 | 35.8K | +5% |
| FY2016 | 34.1K | +26% |
| FY2015 | 27.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY22 | 1.9M | +30% | |
| Q4 FY21 | 1.9M | +42% | |
| Q3 FY21 | 1.9M | +50% | |
| Q2 FY21 | 1.7M | +33% | |
| Q1 FY21 | 1.5M | +37% | |
| Q4 FY20 | 1.3M | +24% | |
| Q3 FY20 | 1.3M | +105% | |
| Q2 FY20 | 1.2M | +170% | |
| Q1 FY20 | 1.1M | +132% | |
| Q4 FY19 | 1.1M | +740% | |
| Q3 FY19 | 616.8K | +33% | |
| Q2 FY19 | 462.8K | +1193% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Edesa Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.